Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine LAI (TEV-‘749) on September 22, 2025 After Presentations at the Psych Congress Annual meeting 17-09-2025, 03:30

Denodo Recognized as Top Vendor in the Dresner Advisory Active Data Architecture™ Report, for Second Time in a Row 5-11-2025, 22:54

European Commission approves label expansion of Roche’s 1-02-2023, 13:17